Nivolumab + daratumumab

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Nivolumab + daratumumab
Treatment and conditionWhere it standsTrials
Nivolumab + daratumumab for neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1